Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Halstead Michael
Intra-Cellular Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(10.525%),Abigail P. Johnson(10.525%)
Intra-Cellular Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(5.9%)
Intra-Cellular Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(5.9%)
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Intra-Cellular Therapies | SC 13G: Statement of acquisition of beneficial ownership by individuals-JPMORGAN CHASE & CO.(5.0%)
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Neumann Mark
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Narula Sanjeev
Intra-Cellular Therapies | 3: Initial statement of beneficial ownership of securities-Officer Narula Sanjeev
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director Salas Eduardo Rene
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director MARCUS JOEL S
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
No Data